Immunobiogram® has been granted a US patent by USPTO

Published On: November 22nd, 2021

Biohope´s lead product, the Immunobiogram®, has been granted a US patent by the United States Patent and Trademark Office. This new patent complements and consolidates  Biohope´s  intellectual property protection facilitating the commercial expansion in a key market for Biohope growth.

Read more about United States Patent and Trademark Office